We are live on
!
Find out more
DA
DSC Advisors Portfolio holdings
AUM
$11M
1-Year Est. Return
5.88%
This Fund
S&P 500
This Quarter
Est. Return
+8.66%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$176M
AUM Growth
+$11.8M
(+7.2%)
Cap. Flow
+$145M
Cap. Flow
% of AUM
82.21%
Top 10 Holdings %
Top 10 Hldgs %
67.24%
Holding
79
New
13
Increased
10
Reduced
24
Closed
26
Top Buys
| 1 |
AET
Aetna Inc
AET
|
+$4.47M |
| 2 |
iShares Russell 2000 Value ETF
IWN
|
+$4.12M |
| 3 |
HCA Healthcare
HCA
|
+$4.11M |
| 4 |
Liberty Global Class A
LBTYA
|
+$2.84M |
| 5 |
SWFT
Swift Transportation Company
SWFT
|
+$2.33M |
Top Sells
| 1 |
Elevance Health
ELV
|
+$5.7M |
| 2 |
Biogen
BIIB
|
+$4.41M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$3.02M |
| 4 |
DVAX
Dynavax Technologies
DVAX
|
+$1.63M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.45M |
Sector Composition
| 1 | Healthcare | 46.65% |
| 2 | Financials | 21.92% |
| 3 | Materials | 6.36% |
| 4 | Communication Services | 5.46% |
| 5 | Technology | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOMX
1
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $17.3M | 9.82% |
1,560,000
-107,377
| -6% | -$1.01M |
|
2
JPMorgan Chase
JPM
$912B
| $13.6M | 7.71% |
157,606
-328
| -0.2% | -$25K |
|
3
Goldman Sachs
GS
$323B
| $13.2M | 7.49% |
55,168
-9
| -0% | -$1.83K |
|
4
Cardinal Health
CAH
$53.6B
| $13M | 7.35% |
180,000
-220
| -0.1% | -$15.9K |
|
5
CVS Health
CVS
$136B
| $12M | 6.79% |
151,750
-159
| -0.1% | -$12.9K |
|
|
6
HCA Healthcare
HCA
$85.6B
| $11.9M | 6.74% |
160,462
+54,831
| +52% | +$4.11M |
|
|
BERY
7
DELISTED
Berry Global Group, Inc.
BERY
| $11.2M | 6.36% |
250,470
| – | – |
|
|
NSTG
8
DELISTED
NanoString Technologies, Inc.
NSTG
| $10.4M | 5.88% |
465,000
| – | – |
|
|
AET
9
DELISTED
Aetna Inc
AET
| $10.2M | 5.8% |
82,536
+37,373
| +83% | +$4.47M |
|
|
10
iShares Russell 2000 Value ETF
IWN
$14.4B
| $5.84M | 3.31% |
49,080
+37,320
| +317% | +$4.12M |
|
|
PARA
11
DELISTED
Paramount Global Class B
PARA
| $5.41M | 3.07% |
85,000
| – | – |
|
12
Aptiv
APTV
$12.5B
| $5.05M | 2.86% |
75,000
| – | – |
|
|
PFNX
13
DELISTED
Pfenex Inc.
PFNX
| $4.63M | 2.62% |
510,000
| – | – |
|
14
iShares Russell 2000 Growth ETF
IWO
$14.7B
| $4.58M | 2.6% |
29,740
+15,580
| +110% | +$2.33M |
|
15
TE Connectivity
TEL
$59.1B
| $4.37M | 2.48% |
63,000
| – | – |
|
16
Zevra Therapeutics
ZVRA
$754M
| $4.3M | 2.44% |
91,200
+32,232
| +55% | +$1.98M |
|
|
NEOS
17
DELISTED
Neos Therapeutics, Inc
NEOS
| $4.06M | 2.3% |
693,582
-91,122
| -12% | -$617K |
|
18
Herc Holdings
HRI
$5.11B
| $2.71M | 1.54% |
67,500
+21,241
| +46% | +$767K |
|
19
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $2.61M | 1.48% |
2,000,000
+340,700
| +21% | +$74.4M |
|
|
SWFT
20
DELISTED
Swift Transportation Company
SWFT
| $2.44M | 1.38% |
+100,000
| New | +$2.33M |
|
21
Amgen
AMGN
$201B
| $2.23M | 1.27% |
15,274
-57
| -0.4% | -$8.58K |
|
|
22
Liberty Global Class A
LBTYA
$3.63B
| $1.91M | 1.08% |
+90,000
| New | +$2.84M |
|
|
ATH
23
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $1.2M | 0.68% |
+25,000
| New | +$1.16M |
|
24
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $1.14M | 0.65% |
+500,000
| New | +$30.9M |
|
25
Vericel Corp
VCEL
$2.44B
| $1.09M | 0.62% |
+363,569
| New | +$935K |
|
Similar funds
RJTCONH
HSC
BGC
ACM
AG
RVM
JDR
KM
DSC Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, DSC Advisors held 79 positions worth $176M, up 7.2% from $165M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
DSC Advisors deployed $145M of net new capital in Q4 2016, opening 13 new positions and adding to 10 existing holdings. Its largest new stake was Liberty Global Class A: 90,000 shares worth $1.91M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 54% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Foamix Pharmaceuticals Ltd. Ordinary Shares, an estimated $1.01M trimmed.
- DSC Advisors's largest Q4 2016 buy was Liberty Global Class A: 90,000 shares worth $1.91M.
- DSC Advisors added most to Aetna Inc in Q4 2016, an estimated $4.47M increase.
- DSC Advisors's biggest Q4 2016 reduction was Foamix Pharmaceuticals Ltd. Ordinary Shares, cutting an estimated $1.01M.
- DSC Advisors fully exited Elevance Health in Q4 2016, selling an estimated $5.7M.
- DSC Advisors's ten largest holdings make up 67% of its $176M portfolio in Q4 2016.
- DSC Advisors opened 13 new positions and closed 26 in Q4 2016.
- DSC Advisors's portfolio value rose 7.2% quarter-over-quarter to $176M.
Based on DSC Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.